Overview

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Status:
Recruiting

Trial end date:
2025-06-01

Target enrollment:

Participant gender:

Summary

To assess if PD-L1 expression can be upregulated in peritoneal metastases from gastric cancer after the administration of HIPEC with greater frequency compared to systemic chemotherapy alone

Phase:

Phase 2

Details

Lead Sponsor:

University of Chicago

Treatments:

Cisplatin
Mitomycin
Mitomycins